Emma J.D. Padilla

HSD17B4 overexpression, an independent biomarker of poor patient outcome in prostate cancer

Vanessa M. Hayes, Margaret Gardiner-Garden, Jerzy Adamski, 2009, Molecular and Cellular Endocrinology.

The Common Variant rs1447295 on Chromosome 8q24 and Prostate Cancer Risk: Results from an Australian Population-Based Case-Control Study

D. English, G. Giles, G. Severi, 2007, Cancer Epidemiology Biomarkers & Prevention.

Mammographic Density and Candidate Gene Variants: A Twins and Sisters Study

John L Hopper, Lyle C Gurrin, Gillian S Dite, 2007, Cancer Epidemiology Biomarkers & Prevention.

The rs743572 common variant in the promoter of CYP17A1 is not associated with prostate cancer risk or circulating hormonal levels

D. English, P. Boyle, G. Giles, 2007, BJU international.

5α‐Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia

D. English, P. Boyle, G. Giles, 2007, International journal of cancer.

The E211 G>A Androgen Receptor Polymorphism Is Associated with a Decreased Risk of Metastatic Prostate Cancer and Androgenetic Alopecia

G. Giles, G. Severi, J. Hopper, 2005, Cancer Epidemiology Biomarkers & Prevention.

Variants in the Prostate-Specific Antigen (PSA) Gene and Prostate Cancer Risk, Survival, and Circulating PSA

D. English, P. Boyle, G. Giles, 2006, Cancer Epidemiology Biomarkers & Prevention.

Macrophage Inhibitory Cytokine-1 H6D Polymorphism, Prostate Cancer Risk, and Survival

D. English, G. Giles, G. Severi, 2006, Cancer Epidemiology Biomarkers & Prevention.